Partners Group Holding, a global private markets firm, has, on behalf of its clients, agreed to acquire a 75% stake in Eolo, an Italy-based fixed wireless access (FWA) broadband provider, from Searchlight Capital Partners and Cometa, an entity owned by Elmec Group and EOLO’s founder and CEO, Luca Spada. The transaction values Eolo at an […]
Kellerhals Carrard has acted as legal counsel to Stille, a medical device company, in acquiring all shares in Switzerland-based S&T, a manufacturer of microsurgical instruments, in exchange for CHF 6 million paid in cash
Advestra acted as legal counsel to One Equity Partners, a middle market private equity firm, in completing the acquisition of a 29 percent stake in Cicor Technologies (SIX Swiss Exchange: CICN), a Swiss provider of electronic
Givaudan, a Swiss manufacturer of flavours, fragrances and active cosmetic ingredients, has acquired a 25% stake in B. Kolormakeup & Skincare, an Italy-based company specialized in developing and producing end to end products in make-up and
Heuking Kühn Lüer Wojtek acted as legal counsel to Prose Group on the sale of its testing division, based in Germany and Switzerland, to Germany-based Tüv Süd, for an undisclosed consideration. &
Kuehne & Nagel International, a Switzerland-based provider of transport, logistics and supply chain management solutions, enters into a binding agreement to acquire 100% of the shares in Salmosped. The Oslo-based company is a Norwegian perishables freight
Switzerland based Dietrich Engineering Consultants has announced the acquisition of UK based Biotech and pharmaceutical system provider, Extract Technology, from Wabash National Corp, a U.S. listed trailer manufacturing company. The acquisition included Extract Technology
Switzerland-based global private markets firm, Partners Group, has, on behalf of its clients, agreed to acquire Pharmathen, a Greece-based pharmaceutical company, from international U.S. based investment firm BC Partners. The transaction values Pharmathen at
Ermenegildo Zegna Group, the privately-held Italian fashion company, will go public on the New York Stock Exchange later this year by way of a merger with Investindustrial Acquisition Corp., a special purpose acquisition corporation – or
Kuros Biosciences, a bone graft technologies company, has entered into a royalty purchase agreement with Xoma Corporation, under which Xoma has purchased a proportion of the potential future pre-commercial milestone payments and all the potential
